Home   About the Journal  Editorial Board Reviewers   Online Journal  Writing Norm  Advertisement  Contact Us
You are here:Home => Online Journal => 3期 => 综述 =>
肝硬化患者稀释性低钠血症的研究现状与展望
Research state and prospect of hyponatremia in cirrhosis
文章发布日期:2011年02月12日  来源:  作者:胡玉琳 全香兰  点击次数:6122次  下载次数:988次
分享道
Adjust font size:Small regular big

【摘要】:稀释性低钠血症(DH)是肝硬化腹水患者常发生的一个并发症,并与难以控制的腹水、肝性脑病(HE)、自发性细菌性腹膜炎(SBP)及肝肾综合征(HRS)密切相关。肝硬化患者DH,轻者可表现为疲乏无力、肌张力低,重者可出现低钠性脑病,表现为认知、运动功能障碍,严重者可出现抽搐或昏迷。肝移植前存在DH的患者,其移植后的并发症和病死率明显增加。治疗上限制水摄入、输入白蛋白以纠正DH,严重低钠血症,静脉补充高张钠。几种非肽V2受体拮抗剂有望在肝硬化患者DH的治疗上发挥一定的作用。
【Abstract】:Dilutional hyponatremia (DH) is a common complication of patients diagnosed with cirrhosis and is closely related with refractory ascites, hepatic encephalopathy(HE), spontaneous bacterial peritonitis (SBP) and hepatorenal syndrome (HRS). The common symptoms of hepatocirrhotic patients with mild dilutional hyponatremia are fatigue and muscle weakness. The clinical manifestations of severe cases can be encephalopathy characterized by cognitive and motor disturbances, even convulsion or coma. If the patients preparing for liver transplantation have dilutional hyponatremia, the complications and death occur more often after the transplantation. The treatments for dilutional hyponatremia include water restriction and albumin transfusion. Injection of hypertonic saline is necessary for treating severe hyponatremia. Several non-peptide V2 receptor antagonists are likely to play a role in the treatment of dilutional hyponatremia.
【关键字】:肝硬化;低钠血症
【Key words】:liver cirrhosis; hyponatremia
【引证本文】:

Mail address: Editorial Office of Journal of Clinical Hepatology, 519 Dongminzhu Street, Changchun, Jilin, China Postal code: 130061 Tel:+86-431-88782542/3542
Journal of Clinical Hepatology Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号